FDA limits J&J vaccine use due to blood clot risks



The United States Food and Drug Administration announced on Friday that has narrowed the use of the Johnson & Johnson Covid-19 vaccine to use by adults unwilling or unable to receive the Pfizer-Bi…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento